Atlassian Co. (NASDAQ:TEAM – Get Free Report) CAO Gene Liu sold 165 shares of the business’s stock in a transaction dated Tuesday, November 19th. The stock was sold at an average price of $245.84, for a total transaction of $40,563.60. Following the transaction, the chief accounting officer now owns 56,423 shares in the company, valued at $13,871,030.32. The trade was a 0.29 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link.
Gene Liu also recently made the following trade(s):
- On Monday, November 11th, Gene Liu sold 785 shares of Atlassian stock. The shares were sold at an average price of $240.00, for a total transaction of $188,400.00.
- On Thursday, November 7th, Gene Liu sold 445 shares of Atlassian stock. The stock was sold at an average price of $230.00, for a total transaction of $102,350.00.
- On Friday, November 1st, Gene Liu sold 1,024 shares of Atlassian stock. The shares were sold at an average price of $225.45, for a total transaction of $230,860.80.
Atlassian Stock Performance
NASDAQ TEAM traded down $2.28 during trading on Wednesday, reaching $245.45. 1,515,555 shares of the company’s stock were exchanged, compared to its average volume of 1,868,356. The company has a debt-to-equity ratio of 0.96, a current ratio of 1.18 and a quick ratio of 1.18. The stock has a market capitalization of $63.92 billion, a P/E ratio of -162.98 and a beta of 0.71. Atlassian Co. has a fifty-two week low of $135.29 and a fifty-two week high of $258.69. The business has a 50 day moving average price of $191.18 and a 200-day moving average price of $175.45.
Wall Street Analyst Weigh In
Several analysts have recently weighed in on the company. Mizuho boosted their target price on Atlassian from $200.00 to $240.00 and gave the company an “outperform” rating in a report on Friday, November 1st. Barclays cut their price target on Atlassian from $275.00 to $250.00 and set an “overweight” rating for the company in a report on Monday, August 5th. Raymond James increased their price target on Atlassian from $200.00 to $250.00 and gave the stock an “outperform” rating in a research note on Friday, November 1st. UBS Group boosted their price target on Atlassian from $180.00 to $205.00 and gave the company a “neutral” rating in a research report on Tuesday, October 22nd. Finally, Robert W. Baird raised their target price on shares of Atlassian from $175.00 to $200.00 and gave the company a “neutral” rating in a research note on Friday, November 1st. Nine research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $244.21.
Check Out Our Latest Stock Report on Atlassian
Institutional Trading of Atlassian
Several institutional investors and hedge funds have recently modified their holdings of TEAM. Dragoneer Investment Group LLC bought a new stake in Atlassian during the 2nd quarter worth $469,803,000. Price T Rowe Associates Inc. MD raised its position in shares of Atlassian by 8.8% during the first quarter. Price T Rowe Associates Inc. MD now owns 11,141,645 shares of the technology company’s stock worth $2,173,847,000 after acquiring an additional 904,138 shares during the last quarter. Point72 Asset Management L.P. lifted its position in shares of Atlassian by 760.5% in the 3rd quarter. Point72 Asset Management L.P. now owns 698,775 shares of the technology company’s stock worth $110,972,000 after purchasing an additional 617,566 shares during the period. Two Sigma Advisers LP boosted its position in Atlassian by 122.0% during the third quarter. Two Sigma Advisers LP now owns 1,003,600 shares of the technology company’s stock valued at $159,382,000 after acquiring an additional 551,500 shares during the last quarter. Finally, Manning & Napier Advisors LLC bought a new stake in shares of Atlassian during the 2nd quarter valued at about $91,072,000. 93.03% of the stock is currently owned by institutional investors.
About Atlassian
Atlassian Corporation, through its subsidiaries, designs, develops, licenses, and maintains various software products worldwide. Its product portfolio includes Jira Software and Jira Work Management, a project management system that connects technical and business teams so they can better plan, organize, track and manage their work and projects; Confluence, a connected workspace that organizes knowledge across all teams to move work forward; and Trello, a collaboration and organization product that captures and adds structure to fluid and fast-forming work for teams.
Read More
- Five stocks we like better than Atlassian
- What Are the U.K. Market Holidays? How to Invest and Trade
- Target Results Are Not a Retail Bellwether: Why the Dip Is a Buy
- Profitably Trade Stocks at 52-Week Highs
- Williams-Sonoma Stock: Buy It and Never Let It Go
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- 5 Dividend ETFs to Buy and Hold Forever
Receive News & Ratings for Atlassian Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Atlassian and related companies with MarketBeat.com's FREE daily email newsletter.